Diabetic Macular Edema (DME) Withdrawn Phase Trials for Bevacizumab (DB00112)

Also known as: Diabetic Macular Edema(DME) / Diabetic Macular Oedema / Macular Edema, Diabetic / Diabetic Macular Edema / Macular edema due to diabetes mellitus (disorder) / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04067856Intravitreal Dexamethasone Implant (Ozurdex) Versus Bevacizumab in Patients With Diabetic Macular Edema Undergoing Cataract SurgeryTreatment